0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Other Articles |

HEXYLRESORCINOL IN THE TREATMENT OF PYELITIS OF INFANCY AND OF CHILDHOOD

WILLIAM J. SCOTT, M.D.; VEADER LEONARD, M.D.
Am J Dis Child. 1926;31(2):241-249. doi:10.1001/archpedi.1926.04130020093010.
Text Size: A A A
Published online

Because such measures as renal pelvic lavage cannot be employed in young children with the same facility as in adults, a more efficient internal urinary antiseptic, which could be administered by mouth without danger, would seem to be a particularly welcome addition to our present methods of treating the urinary infections of infancy and childhood. It was with great interest, therefore, that we undertook the clinical application of hexylresorcinol in this group of cases.

As has been pointed out,1 hexylresorcinol2 is the substance described as meeting all of the experimental qualifications enumerated by Davis and his co-workers3 as essential to an internal urinary antiseptic. The experimental facts, on which its clinical employment is based, are as follows:

  1. It is a stable chemical compound.

  2. It is nontoxic in therapeutic doses.

  3. It is nonirritating to the urinary tract.

  4. It is bactericidal in high dilution in urine of any reaction.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();